Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Rollier CS"'
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
Autor:
Dold, C, Marsay, L, Wang, N, Silva-Reyes, L, Clutterbuck, E, Paterson, GK, Sharkey, K, Wyllie, D, Beernink, PT, Hill, AV, Pollard, AJ, Rollier, CS
Adenoviral-vectored vaccines are licensed for prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Ebola virus, but, for bacterial proteins, expression in a eukaryotic cell may affect the antigen's localization and conformat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::fb7f2ddaff5854b1adad4f9a2f62080b
https://ora.ox.ac.uk/objects/uuid:8c7167e6-a279-48fb-9adf-2d8b3c810cac
https://ora.ox.ac.uk/objects/uuid:8c7167e6-a279-48fb-9adf-2d8b3c810cac
Autor:
Marsay, L, Dold, C, Paterson, GK, Yamaguchi, Y, Derrick, JP, Chan, H, Feavers, IM, Maiden, MCJ, Wyllie, D, Hill, AV, Pollard, AJ, Rollier, CS
Publikováno v:
Marsay, L, Dold, C, Paterson, G K, Yamaguchi, Y, Derrick, J, Chan, H, Feavers, I M, Maiden, M C J, Wyllie, D, Hill, A V, Pollard, A J & Rollier, C S 2022, ' Viral vectors expressing group B meningococcal outer membrane proteins induce strong antibody responses but fail to induce functional bactericidal activity ', Journal Of Infection, vol. 84, no. 5, pp. 658-667 . https://doi.org/10.1016/j.jinf.2022.02.032
Marsay, L, Dold, C, Paterson, G K, Yamaguchi, Y, Derrick, J P, Chan, H, Feavers, I M, Maiden, M C J, Wyllie, DH, Hill, A V, Pollard, A J & Rollier, C S 2022, ' Viral Vectors Expressing Group B Meningococcal Outer Membrane Proteins Induce Strong Antibody Responses but Fail to Induce Functional Bactericidal Activity in Mice ', Journal of Infection, vol. 84, no. 5, pp. 658-667 . https://doi.org/10.1016/j.jinf.2022.02.032
Marsay, L, Dold, C, Paterson, G K, Yamaguchi, Y, Derrick, J P, Chan, H, Feavers, I M, Maiden, M C J, Wyllie, DH, Hill, A V, Pollard, A J & Rollier, C S 2022, ' Viral Vectors Expressing Group B Meningococcal Outer Membrane Proteins Induce Strong Antibody Responses but Fail to Induce Functional Bactericidal Activity in Mice ', Journal of Infection, vol. 84, no. 5, pp. 658-667 . https://doi.org/10.1016/j.jinf.2022.02.032
Objective Adenoviral vectored vaccines, with the appropriate gene insert, induce cellular and antibody responses against viruses, parasites and intracellular pathogens such as Mycobacterium tuberculosis. Here we explored their capacity to induce func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb6b584cbdc35569dbe0a54d7932ea4
https://doi.org/10.1016/j.jinf.2022.02.032
https://doi.org/10.1016/j.jinf.2022.02.032
Autor:
Rollier, CS, Dold, C, Blackwell, L, Linder, A, Silva-Reyes, L, Clutterbuck, E, Davis, K, Ford, K, Liu, X, Holland, A, Chan, H, Harbinson, H, O'Connor, D, Borrow, R, Snape, MD, Pollard, AJ
Publikováno v:
Vaccine. 40(32)
The clinical development of the meningococcal vaccine, 4CMenB, included 2 doses in vaccine-naïve adolescents, which was considered unlikely to be cost-effective for implementation. Theoretically, priming with 4CMenB in early childhood might drive st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a65d7fd38e215cce55cbe4d988463878
https://pubmed.ncbi.nlm.nih.gov/35697571
https://pubmed.ncbi.nlm.nih.gov/35697571
Publikováno v:
Cellbioscience. 12(1)
BackgroundDisease caused by the capsular group B meningococcus (MenB) is the leading cause of infectious death in UK infants. A novel adenovirus-based vaccine encoding the MenB factor H binding protein (fHbp) with an N-terminal dual signal sequence i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128712e8cca38c583af59db4ee6dfbf2
https://pubmed.ncbi.nlm.nih.gov/35690803
https://pubmed.ncbi.nlm.nih.gov/35690803
The development of an effective vaccine against respiratory syncytial virus (RSV) has been hampered by major difficulties that occurred in the 1960s when a formalin-inactivated vaccine led to increased severity of RSV disease after acquisition of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::13d70802db136612e2b779b9c1101eb0
Autor:
Verstrepen BE, Depla E, Rollier CS, Mares G, Drexhage JA, Priem S, Verschoor EJ, Koopman G, Granier C, Dreux M, Cosset FL, Maertens G, Heeney JL, Verstrepen, Babs E, Depla, Erik, Rollier, Christine S, Mares, Gwenny, Drexhage, Joost A R, Priem, Sofie, Verschoor, Ernst J
Publikováno v:
Journal of Infectious Diseases; 9/15/2011, Vol. 204 Issue 6, p837-844, 8p
Autor:
Marsay, L, Dold, C, Green, CA, Rollier, CS, Norheim, G, Sadarangani, M, Shanyinde, M, Brehony, C, Thompson, AJ, Sanders, H, Chan, H, Haworth, K, Derrick, JP, Feavers, IM, Maiden, MC, Pollard, AJ
Publikováno v:
Journal of Infection. (3):326-337
OBJECTIVES: Outer membrane vesicle (OMV) vaccines are used against outbreaks of capsular group B Neisseria meningitidis (MenB) caused by strains expressing particular PorA outer membrane proteins (OMPs). Ferric enterobactin receptor (FetA) is another
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::39d849e14192486384047acbb44046b9
Autor:
Pagliari S; School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Dema B; Pandemic Science Institute, Institute of Developmental and Regenerative Medicine (IDRM), University of Oxford, Oxford, UK., Sanchez-Martinez A; School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK., Montalvo Zurbia-Flores G; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Rollier CS; School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. Electronic address: c.rollier@surrey.ac.uk.
Publikováno v:
Journal of molecular biology [J Mol Biol] 2023 Dec 01; Vol. 435 (23), pp. 168297. Date of Electronic Publication: 2023 Oct 04.
Autor:
Belcher T; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Rollier CS; School of Biosciences, University of Surrey, Guilford, United Kingdom., Dold C; The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Ross JDC; Sexual Health and HIV, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom., MacLennan CA; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Aug 17; Vol. 14, pp. 1248613. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).